Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to enhance metabolic stability and binding affinity in drug candidates. Commonly employed in the preparation of small molecule therapeutics targeting inflammatory diseases and certain viral infections. Its trifluoromethyl group contributes to improved lipophilicity and bioavailability in final active ingredients.